Sign in

Forgot Password?

Not signed up yet? Sign up now


Sign up for new account

IBPS Bank PO and Clerk Exam Preparation
IBPS Bank PO and Clerk Exam Preparation
IBPS Bank PO and Clerk Exam Preparation
IBPS Clerk
IBPS Bank PO and Clerk Exam Preparation
IBPS Bank PO and Clerk Exam Preparation
Railways (RRB) Preparation

Already a member? Sign in now

close button

Forgot Password?

Remember your password? Sign in now


Biocon introduces advanced therapy to treat Hepatitis C

bioconBiotechnology major Biocon has launched advanced novel therapy for the treatment of Hepatitis C at low cost. CIMIVIR-L, a fixed dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg, will be made available to patients in India at a fraction of the global cost of the innovator brand. The cost of a 12-week course of this combination therapy in the US is USD 94,500 (about Rs 63 lakh). Biocon, President-Marketing, Ravi Limaye said the introduction of CIMIVIR-LTM will strengthen the company’s current portfolio of virology products.

CIMIVIR-L is an equivalent of the innovator product commercialised by Gilead Sciences in the US. Biocon had entered into a licensing agreement last year with US-based Gilead to manufacture and commercialise its chronic Hepatitis-C blockbuster product range, Sofosbuvir and Sofosbuvir-Ledipasvir combination in India and in select emerging markets. Read More

Comment Here

Download our Android app to Study Anywhere, Anytime

Studycopter's Android App is used by thousands of users to practice & study for IBPS prelim and mains exams for PO, Clerk, and SO. Get it now to get a top IBPS exam score


Like our Facebook page to get exam updates, current affairs, exam tips etc.